Yüklüyor......
PCSK9: From Basic Science Discoveries to Clinical Trials
Unknown fifteen years ago, proprotein convertase subtilisin/kexin type 9 (PCSK9) is now common parlance amongst scientists and clinicians interested in prevention and treatment of atherosclerotic cardiovascular disease. What makes this story so special is not its recent discovery nor the fact that i...
Kaydedildi:
| Yayımlandı: | Circ Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5976255/ https://ncbi.nlm.nih.gov/pubmed/29748367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.118.311227 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|